Main content

    Cardiology Clinical Trials

    Heart Failure, LVAD & Heart Transplant ProgramOpens new window

    Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Active Studies

    Title: MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol
    Description: The objective of the study is to continue to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study.
    Investigator: Brett Sheridan, MD
    Eligibility: Subjects, 18 y/o and older, with a BSA ≥ 1.2 m², NYHA Class III with dyspnea upon mild physical activity, or NYHA Class IV; LVEF ≤ 25%; and inotrope dependent OR CI < 2.2 L/min/m2, while not on inotropes
    Status: Active and open to enrollment
    Contact: Gisselle Stone, 415-600-5772, Email: Gisselle Stone about Study Momentum 3 CAP
    Contact: Douglas Raggett, RN, 415-600-3777, Email: about Study Momentum 3 CAP

    • updated December 2016